drugset / Trial / NCT07215000

Cleansing Options in Out-Patient Setting to Improve Tolerance (COOP SIT) Trial

NCT07215000

Phase 4 Recruiting 300 enrolled Morehouse School of Medicine
RandomizedSingle-groupOpen-labelPrevention

Summary

The purpose of this research is to compare patient preferences for two bowel preparation options: low-volume tablets (Suflave/Sutab) versus the standard colon preparation using Golytely (polyethylene glycol). The study aims to enroll approximately 300 patients, who will be randomly assigned to one of the two preparation methods in a 2:1 ratio prior to their scheduled colonoscopy appointments. Surveys will be conducted both before and after the procedures. This project will be conducted over a 12-month period and seeks to compare patient experience of both preparation methods in an outpatient setting. The study will evaluate the rate of preparation completion, patient satisfaction, tolerance of the solutions, and the endoscopic adequacy of each method. Eligible participants are patients aged 18 or older with upcoming colonoscopy appointments who can provide informed consent in English or Spanish. There is no health risks associated with this study, as both bowel preparation methods are FDA-approved and commonly used in clinical practice.

Timeline

Start
2025-10-01
Primary completion
2027-01
Completion
2027-06

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject SUFLAVE Unknown Oral
Subject SUTAB Unknown Oral
Comparator polyethylene glycol Other / unclassified 4000 ml Oral

Indications